Gain Therapeutics
GANX
GANX
35 hedge funds and large institutions have $11.9M invested in Gain Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.54% more ownership
Funds ownership: 10.11% → 12.65% (+2.5%)
Holders
35
Holding in Top 10
–
Calls
$77K
Puts
–
Top Buyers
| 1 | +$2M | |
| 2 | +$503K | |
| 3 | +$491K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$257K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$216K |
Top Sellers
| 1 | -$143K | |
| 2 | -$41.9K | |
| 3 | -$38.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$27.4K |
| 5 |
SI
Sprott Inc
Toronto,
Ontario, Canada
|
-$26.7K |
